Skip to main content
    E

    Envoy Medical Inc. (COCH)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $6.87
    -0.05 (-0.72%)

    Market Cap: $53.59M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Envoy Medical Inc. (COCH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Envoy Medical (COCH) has a market cap of $53.59M and an enterprise value of $39.02M. It kept -9026.41% of revenue as net income over the last 12 months. Its share count is up 377.51% from a year earlier.

    Total Valuation

    Enterprise value is 27.19% below the market cap, as cash exceeds debt.

    Market Cap$53.59M
    Enterprise Value$39.02M
    Latest price (Nov 17, 2026)$6.87

    Key Dates

    The next earnings report is expected on Mar 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 22, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 89.97% in the quarter ended Sep 30, 2026 and shrank 25.13% a year over 2 years.

    Shares Outstanding10.43M
    Shares Change (YoY)+377.51%
    Shares Change (QoQ)-89.97%
    Share Count Growth (2Y CAGR)-25.13%

    Valuation Ratios

    The price to sales ratio is 310.3x.

    P/S Ratio310.3x
    Forward P/S226.1x

    Price Statistics

    The stock is up 2.86% over 52 weeks and trades 1.33% above its 50-day average.

    Beta (1Y)1.24
    52-Week Change+2.86%
    1-Month Change+5.05%
    3-Month Change-7.16%
    6-Month Change-7.16%
    5-Year Change-93.19%
    Total Return (1Y)+2.86%
    Total Return (3Y CAGR)-8.94%
    Total Return (5Y CAGR)-41.20%
    Return vs SPY (1Y)-21.88%
    Max Drawdown (1Y)-54.00%
    Max Drawdown (3Y)-96.08%
    Sharpe Ratio (1Y)-0.12
    Correlation with SPY (1Y)0.19
    50-Day Average$6.78
    200-Day Average$6.88
    52-Week Range$3.63 to $9.54
    RSI (14 Days)52.6
    Average Volume (20 Days)80.23K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.21x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.21x
    Quick Ratio1.10x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on Assets (ROA)-108.84%
    Return on Capital Employed (ROCE)-426.58%
    ROIC (5Y Average)339.66%
    Asset Turnover0.02x
    Inventory Turnover0.68x
    Receivables Turnover3.45x
    Cash Conversion Cycle14 days

    Scores

    COCH has an Altman Z-Score of -25.51, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-25.51
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $231.00K over the last 12 months is up 11.06% from the 12 months before.

    Revenue$231.00K
    Revenue Growth (YoY)+11.06%
    Gross Profit-$815.00K
    Operating Income-$23.45M
    Pretax Income-$20.85M
    Net Income-$20.85M
    EBITDA-$19.63M
    EBIT-$20.85M
    Reported EPS (TTM)-$3.32

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$14.57M
    Total Debt$0
    Net Cash$14.57M
    Net Cash Per Share$1.40
    Working Capital$2.99M
    Shareholder Equity-$1.53M
    Total Assets$19.16M
    Total Liabilities$20.30M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $205.00K of capital spending, operating cash flow left -$22.44M of free cash flow.

    Operating Cash Flow-$22.23M
    Capital Expenditures$205.00K
    Free Cash Flow-$22.44M
    FCF Per Share-$2.90
    Depreciation and Amortization$1.22M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -10151.52%.

    Gross Margin-352.81%
    Operating Margin-10151.52%
    Pretax Margin-9026.41%
    Net Margin-9026.41%
    EBITDA Margin-8496.97%
    EBIT Margin-9026.41%
    FCF Margin-9712.99%

    Dividends and Yields

    COCH does not pay a dividend. Its free cash flow yield is -31.30%.

    FCF Yield-31.30%
    Buyback Yield-43.70%

    Stock Splits

    The last split was a 1-for-10 reverse split on Oct 26, 2026.

    Last Split DateOct 26, 2026
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 12 similar companies, COCH has the highest P/S.

    P/S Ratio310.3x vs 1.7x median
    Revenue Growth (Trailing 4 Quarters, YoY)+11.06% vs +9.04% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 6.50% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+6.50%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About COCH

    What is COCH's market cap?

    Envoy Medical has a market cap of $53.59M. Its enterprise value, which adds debt and subtracts cash, is $39.02M.

    How many shares of COCH are outstanding?

    Envoy Medical has 10.43M shares outstanding. The count is up 377.51% from a year earlier.

    Does COCH pay a dividend?

    No. Envoy Medical does not pay a dividend.

    How much debt does COCH have?

    Envoy Medical has $0 of total debt and $14.57M of cash and equivalents, a net cash position of $14.57M.